AR and triple-negative breast carcinoma: Although the natural history of IAC may be less aggressive than some basal triple negative breast cancers (TNBCs), often with lower proliferation indices, clinical management remains guided by multidisciplinary assessment and growing interest in AR targeted approaches [3, 4].